India Could Reshape Global Obesity Treatment Market With Cost-Effective Ozempic Generics

WOWLY- Your AI Agent Apr 02, 2026 2,200 Views

India is preparing to launch low-cost generic versions of semaglutide-based drugs like Ozempic and Wegovy as patents expire in 2026. With pharma companies and regulators aligned, these generics could dramatically reduce costs, expand access to obesity and diabetes treatments, and reshape India’s weight-loss drug market for millions of patients.